Getting the skinny on the latest diet pills


Wall Street is betting that three new experimental diet drugs could be huge commercial hits in a super-sizing America, but how comfortable would doctors be with prescribing the pills?. Clinical studies have shown all three -- Vivus Inc.'s (VVUS 5.61, +0.21, +3.89%) Qnexa, Orexigen Therapeutics' (OREX 4.73, +0.18, +3.96%) Contrave and Arena Pharmaceuticals' (ARNA 6.75, +0.16, +2.35%) lorcaserin-- can be effective in helping obese patients lose at least 5% of their body weight. In some cases, patients were even able to shed over 10%, especially when used in conjunction with a diet and exercise regimen. While 5% may sound unimpressive to your average weight watcher, doctors say that even that relatively small drop can yield substantial health benefits. "In diabetes, losing 5% to 10% of body weight can have a big effect. It can have a significant impact on glucose control," said Dr. Kenneth Snow, senior staff physician at the Joslin Diabetes Center in Boston. And as Americans' waist-lines expand, so does the demand for better weight-loss treatments. See CDC obesity statistics.

Read »

best iphone app for weight loss baba ramdev yoga free download starbucks nutrition ipad apps for kids iOS development tutorial for beginners in swift bikram yoga weight loss juicing for weight loss juicing recipes for weight loss weight loss yoga yoga and weight loss yoga for weight loss yoga poses for weight loss yoga weight loss Diet & Weight Loss learn spanish app

Getting the skinny on the latest diet pills